Latest Breaking News On - Michael coyle - Page 24 : comparemela.com

First published on iRhythm Technologies is grappling with a hazy road ahead after a regional Medicare rate setter cut reimbursement for longer-term cardiac monitoring by roughly $200, leading the once-market leader to pull services out of the fee-for-service program. The unexpected news pushed iRhythm s stock price down nearly 40% Monday. The company has now seen a 12-month run, where the stock price more than tripled, erased in just a few months. Wall Street is now questioning the company s value. Some analysts still contend that the company can grow its business and volumes in the long-term, while others are more cautious. This is a really challenging period ahead, and the dust has not settled, said Baird analyst Mike Polark.

United statesMike polarkMichael coyleWilliam blairNovitas solutionsPreventice solutionsBoston scientificRhythm technologiesMedicare administrative contractorPhysician feeHealth itஒன்றுபட்டது மாநிலங்களில்மைக்கேல் கோய்ல்வில்லியம் பிளேயர்போஸ்டன் அறிவியல்தாளம் தொழில்நுட்பங்கள்